Announcement on Obtaining Approval of Phase II Clinical Trial for New Indication of Project SY-009

About this update from Yabao Pharmaceutical Group Co. Ltd. Class A

Announcement on Obtaining Approval of Phase II Clinical Trial for New Indication of Project SY-009The abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Yabao Pharmaceutical Group Co. Ltd. Class A